The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of Aspergillosis
Author(s) -
John R. Perfect,
G. M. Cox,
J. Y. Lee,
Carol A. Kauffman,
Louis de Repentigny,
Stanley W. Chapman,
V. A. Morrison,
Peter G. Pappas,
J. Hiemenz,
D. A. Stevens
Publication year - 2001
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/323900
Subject(s) - aspergillosis , aspergilloma , medicine , allergic bronchopulmonary aspergillosis , neutropenia , aspergillus , aspergillus fumigatus , disease , immunosuppression , immunology , intensive care medicine , transplantation , microbiology and biotechnology , biology , chemotherapy , antibody , immunoglobulin e
The term "aspergillosis" comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on the diagnosis, risk factors, management, and outcome associated with these diseases. Most Aspergillus culture isolates from nonsterile body sites do not represent disease. However, for high-risk patients, such as allogeneic bone marrow transplant recipients (60%), persons with hematologic cancer (50%), and those with signs of neutropenia (60%) or malnutrition (30%), a positive culture result is associated with invasive disease. When such risk factors as human immunodeficiency virus infection (20%), solid-organ transplantation (20%), corticosteroid use (20%), or an underlying pulmonary disease (10%) are associated with a positive culture result, clinical judgment and better diagnostic tests are necessary. The management of invasive aspergillosis remains suboptimal: only 38% of patients are alive 3 months after diagnosis. Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom